Table 1.
Clinical Characteristics of the Study Population
| Variables | Baseline 2007 (n = 1222) |
10-Year Follow-Up 2017 (n = 1222) |
|---|---|---|
| Male, n (%) | 445 (36.4%) | 445 (36.4%) |
| Age (years) | 46 (41–53) | 56 (51–63) |
| Body mass index (kg/m2) | 23.7 (21.6–26.0) | 24.0 (22.1–26.6) |
| Systolic blood pressure (mmHg) | 112 (110–130) | 130 (118–141) |
| Diastolic blood pressure (mmHg) | 80 (70–80) | 73 (66–80) |
| Serum creatinine (mg/dL) | 0.8 (0.7–1.0) | 0.8 (0.7–1.0) |
| eGFR (mL/min/1.73 m2) | 94.5 (80.9–106.5) | 86.8 (73.7–99.2) |
| Fasting plasma glucose (mg/dL) | 86 (79–94) | 91 (85–101) |
| Serum uric acid (mg/dL) | 4.8 (3.9–6.1) | 5.2 (4.4–6.2) |
| Presence of hyperuricemia, n (%) | 212 (17.3%) | 247 (20.2%) |
| Serum total cholesterol (mg/dL) | 207 (181–234) | 204 (176–233) |
| Serum triglyceride (mg/dL) | 106 (72–154) | 110 (80–150) |
Notes: Data are presented as number (%) or median (interquartile range).
Abbreviations: eGFR, estimated glomerular filtration rate.